CD30 Expression on Human CD8+ T Cells Isolated from Peripheral Blood Lymphocytes of Normal Donors

Journal of Immunology

Volumn 157, Issue 8, 1996, Pages 3229-3234

  Agrawal, Babita ^a,b   Reddish, Mark ^b   Longenecker, B Michael ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b Biomira Inc   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CD3 ANTIGEN; CD30 ANTIGEN; FLUORESCEIN ISOTHIOCYANATE; FLUORESCENT DYE; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; PHYCOERYTHRIN;

ARTICLE; BIOSYNTHESIS; CD8+ T LYMPHOCYTE; CLASSIFICATION; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; IMMUNOLOGY; IN VITRO STUDY; LYMPHOCYTE; METABOLISM; T LYMPHOCYTE SUBPOPULATION;

ANTIBODIES; ANTIGENS, CD3; ANTIGENS, CD30; CD8-POSITIVE T-LYMPHOCYTES; FLOW CYTOMETRY; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; FLUORESCENT DYES; HUMANS; INTERFERON TYPE II; INTERLEUKIN-2; INTERLEUKIN-4; LYMPHOCYTES; PHYCOERYTHRIN; T-LYMPHOCYTE SUBSETS;

EID: 0030587891     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Smith, C., T. Davis, D. Anderson, L. Solam, M. P. Beckmann, R. Jerzy, S. K. Dower, D. Cosman, and R. G. Goodwin. 1990. A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 248:1019.
2. Durkop, H., U. Latza, M. Hummel, F. Eitelbach, B. Seed, and H. Stein. 1992. Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease. Cell 68:421.
3. Mallette, S., and A. N. Barclay. 1991. A new superfamily of cell surface proteins related to the nerve growth factor receptor. Immunol. Today 12:220.
4. Beutler, B., and C. van Huffel. 1994. Unraveling function in the tumor necrosis factor ligand and receptor families. Science 264:667.
5. Smith, C. A., T. Farrah, and R. G. Goodwin. 1994. The tumor necrosis factor receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 76:959.
6. Schwab, U., H. Stein, G. Gerdes, H. Lemke, H. Kirchner, M. Schaadt, and V. Diehl. 1982. Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin' s disease and a subset of normal lymphoid cells. Nature 200:65.
7. Gruss, H. J., N. Boiani, D. E. Williams, R. J. Armitage, C. A. Smith, and R. G. Goodwin. 1994. Pleiotropic effects of CD30 ligand on CD30-expressing cells and lymphoma cell lines. Blood 83:2045.
8. Smith, C. A., H. J. Gruss, T. Davis, D. Anderson, T. Farrah, E. Baker, G. R. Sutherland, C. I. Brannan, N G. Copeland, N. A. Jenkins, K. H. Grabstein, B. Giliniak, I. B. McAlister, W. Fanslow, M. Alderson, B. Falk, S. Gimpel, S. Gillis, W. S. Din, R. G. Goodwin, and R. J. Armitage. 1993. CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to tumor necrosis factor. Cell 73:1349.
9. Wendtner, C.-M., B. Scmitt, H.-J. Grass, B. J. Druker, B. Emmerich, R. G. Goodwin, and M. Hallek. 1995. CD30 ligand signal transduction involves activation of a tyrosine kinase and of mitogen-activated protein kinase in a Hodgkin's lymphoma cell lines. Cancer Res. 55:4157.
10. Tian, Z.-G., D. L. Longo, S. Funakashi, O. Asai, D. K. Ferris, M. Widmer, and W. J. Murphy. 1995. In vivo antitumor effects of unconjugated CD30 monoclonal antibodies on human anaplastic large cell lymphoma xenografts. Cancer Res. 55:5335.
11. Schwab, U., H. Stein, J. Gerdes, H. Lemke, H. Kirchner, M. Schaadt, and V. Diehl. 1982. Production of a monoclonal antibody specific for Hodgkin's disease and a subset of normal lymphoid cells. Nature 299:65.
12. Stein, H., D. Y. Mason, J. Gerdes, N. O'Connor, J. Wainscoat, G. Pallesen, K. Gatter, B. Falini, G. Delsol, H. Lemke, R. Schwarting, and K. Lennert. 1985. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sterberg cells and histiocytes malignancies are derived from activated lymphoid cells. Blood 66:848.
13. Andreesen, R., J. Osterholz, G. W. Lohr, and K. J. Bross. 1984. A Hodgkin cell-specific antigen is expressed on a subset of auto- and alloactivated T (helper) lymphoblasts. Blood 63:1299.
14. + T cells producing Th2-type cytokines. FASEB J. 9:81.
15. Hamann, D., C. M. U. Hilkens, J. L. Grogan, S. M. A. Lens, M. L. Kapsenberg, M. Yazdanbaksh, and R. A. W. van Lier. 1996. CD30 expression does not discriminate between human Th1- and Th2- T cells. J. Immunol. 156:1387.
16. + T cells. J. Immunol. 151:2380.
17. + T cell clones in human immunodeficiency virus infection. J. Exp. Med. 180:2407.
18. Falini, B., S. Pileri, G. Pizzolo, H. Durkop, L. Flenghi, F. Stirpe, M. T. Martelli, and H. Stein. 1995. CD30 (Ki-1) molecule: a new cytokine receptor superfamily as a tool for diagnosis and immunotherapy. Blood 85:1.
19. Borvak, J., C.-S. Chou, K. Bell, G. Van Dyke, H. Zola, O. Ramilo, and E. S. Vitetta. 1995. Expression of CD25 defines peripheral blood mononuclear cells with productive versus latent HIV infection. J. Immunol. 155:3196.
20. Bowen, M. A., R. K. Lee, G. Miragliotta, S. Y. Nam, and E. R. Podack. 1996. Structure and expression of murine CD30 and its role in cytokine production. J. Immunol. 156:442.
21. Del Prete, G., E. Maggi, G. Pizzolo, and S. Romagnani. 1995. CD30, Th2 cytokines and HIV infection: a complex and fascinating link. Immunol. Today 16: 76.
22. Alzona, M., H. M. Jack, R. I. Fischer, and T. M. Ellis. 1994. CD30 defines a subset of activated T cells that produce IFN-γ and IL-5 and exhibit enhanced B cell helper activity. J. Immunol. 153:2861.
23. Alzona, M., H. M. Jack, R. I. Fischer, and T. M. Ellis. 1995. IL-12 activates IFN-γ production through the preferential activation of CD30+ T cells. J. Immunol. 154:9.